Last Posted: Apr 11, 2019
- Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.
Kratz Johannes R et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Apr - Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Friedlaender Alex et al. Frontiers in oncology 2019 9166 - Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Singal Gaurav et al. JAMA 2019 Apr 321(14) 1391-1399 - Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.
Hummelink Karlijn et al. ERJ open research 2019 Feb 5(1) - Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Shin Seo Jeong et al. Journal of medical Internet research 2019 Mar 21(3) e13249 - Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
Ricciuti Biagio et al. Journal for immunotherapy of cancer 2019 Mar 7(1) 87 - Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing.
Dong Jingsi et al. Frontiers in pharmacology 2019 10230 - Biomedical risk assessment as an aid for smoking cessation.
Clair Carole et al. The Cochrane database of systematic reviews 2019 Mar 3CD004705 - Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity.
Ivanov Maxim et al. Frontiers in genetics 2019 10194 - Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Colling Richard et al. Virchows Archiv : an international journal of pathology 2019 Feb 474(2) 187-192
.png)
No hay comentarios:
Publicar un comentario